6885 — BRIM Biotechnology Income Statement
0.000.00%
Last trade - 00:00- TWD3.19bn
- TWD2.15bn
- TWD5.49m
Annual income statement for BRIM Biotechnology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.36 | 0.526 | 0.09 | 0.022 | 5.49 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 1.25 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 93.6 | 219 | 694 | 345 | 458 |
| Operating Profit | -93.2 | -218 | -694 | -345 | -453 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -105 | -274 | -688 | -315 | -451 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -105 | -274 | -688 | -315 | -451 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -105 | -274 | -688 | -315 | -436 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -105 | -274 | -688 | -315 | -436 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.34 | -3.7 | -6.84 | -2.7 | -3.32 |
| Dividends per Share |